Vir Biotechnology (VIR) Non-cash Items (2019 - 2022)

Vir Biotechnology has disclosed Non-cash Items across 4 years of filings, most recently posting $52.3 million for Q4 2022.

• Non-cash Items for Q4 2022 came in at $52.3 million, down 70.35% year-over-year; the trailing twelve-month figure through Dec 2022 was $52.3 million (down 70.35% YoY), and the FY2022 annual result was $52.3 million, down 70.35% from the prior year.
• Non-cash Items came in at $52.3 million for Q4 2022 at Vir Biotechnology, down from $65.5 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $250.2 million in Q2 2020 to a low of $52.3 million in Q4 2022.
• The 4-year median for Non-cash Items is $175.3 million (2020), against an average of $151.6 million.
• Across the five-year window, Non-cash Items surged 98.44% in 2020 and tumbled 70.35% in 2022, its largest moves.
• Vir Biotechnology's Non-cash Items stood at $55.1 million in 2019, then jumped by 98.44% to $109.3 million in 2020, then jumped by 61.43% to $176.4 million in 2021, then sank by 70.35% to $52.3 million in 2022.
• The last three Non-cash Items figures came in at $52.3 million (Q4 2022), $65.5 million (Q1 2022), and $176.4 million (Q4 2021), per Business Quant data.